The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
621
SAFETY, TOLERABILITY, AND PHARMACODYNAMIC EFFECTS OF TPM502, A MIXTURE OF TOLERIZING NANOPARTICLES FOR THE TREATMENT OF CELIAC DISEASE (CED)
Date
May 5, 2025
Explore related products in the following collection:
